Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 2, 2007

Numira Biosciences and Visual Influence Merge

  • R&D tools company Numira Biosciences merged with imaging company Visual Influence, such that Visual Influence will become a wholly-owned subsidiary of Numira.

    "Through this combination,” notes Michael Beeuwsaert, president and CEO. “Numira will be better positioned to deliver more complete solutions and a broader range of leading-edge imaging products for the drug discovery research market."
    Visual Influence will remain in Salt Lake City and its president, David Weinstein, Ph.D., will become Numira's CTO. "We look forward to developing a number of powerful, integrated products that leverage Numira's novel targeted reagent technologies with our visualization software capabilities."

    Visual Influence is a spin-off company from the University of Utah's Scientific Computing and Imaging Institute. It develops high-performance, custom rendering and image analysis software for medical imaging, scientific data management, image processing and analysis, volume visualization, and high-performance computing.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »